| | Genotypes | Allele frequencies |
---|
| n. | GG | GA | AA | G | A |
---|
Total obese subjects*
| 115 | 87 (75.6%) | 26 (22.6%) | 2 (1.8%) | 0.869 | 0.131 |
– Central obesity
#
| 61 | 50 (81.9%) | 11 (18,1%) | - | 0.909 | 0.091 |
– Peripheral obesity
§
| 37 | 28 (75.6%) | 9 (24.4) | - | 0.878 | 0.122 |
Lean subjects | 79 | 58 (73.4%) | 19 (24.%) | 2 (2.%) | 0.854 | 0.146 |
- GG, GA, and AA = TNF-α genotypes. Total obese subjects includes 17 patients whom did not undergo biolectric impedance analysis * Total obese subjects vs controls: genotypes Χ2 = 0.21, df = 2, p < NS; allele frequencies Χ2 = 0.09, df = 1, p < NS. # Central obese subjects vs controls: genotypes Χ2 = 2.4, df = 2, p < NS; allele frequencies Χ2 = 1.4, df = 1, p < NS. § Peripheral obese subjects vs controls: genotypes Χ2 = 0.95, df = 2, p < NS; allele frequencies Χ2 = 0.16, df = 1, p < NS. Central obese subjects vs peripheral obese subjects: genotypes Χ2 = 0.5, df = 1, p = NS; allele frequencies Χ2 = 0.4, df = 1, p = NS. Cutpoints for centrally obese subjects were : WC 94 for men and WC 88 for women